Transcend Therapeutics Overview

  • Year Founded
  • 2021

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 14

Employees

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $1.23B

Transcend Therapeutics General Information

Description

Operator of a neuroscience-focused clinical-stage company intended to develop psychoactive medicines for neuropsychiatric disease. The company's compound targets specific brain areas implicated in the pathophysiology of neuropsychiatric disorders, enabling doctors to help patients promote positive changes in brain function and behavior.

Contact Information

Website
www.transcendtherapeutics.com
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Corporate Office
  • 80 5th Avenue
  • Floor 18
  • New York, NY 10011
  • United States
Primary Industry
Drug Discovery
Other Industries
Other Pharmaceuticals and Biotechnology
Parent Company
Otsuka Pharmaceutical
Vertical(s)
Life Sciences
Corporate Office
  • 80 5th Avenue
  • Floor 18
  • New York, NY 10011
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Transcend Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Merger/Acquisition 12-Jun-2026 $1.23B Completed Clinical Trials - Phase 3
3. Early Stage VC 28-Oct-2024 Completed Clinical Trials - Phase 2
2. Early Stage VC (Series A) 23-Feb-2023 $40M $41.5M Completed Clinical Trials - Phase 2
1. Seed Round 17-Dec-2021 $1.5M $1.5M Completed Startup
To view Transcend Therapeutics’s complete valuation and funding history, request access »

Transcend Therapeutics Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series A-1
Series A
Seed 3,922,184 $0.001000 $0.38 $0.38 1x $0.38 15.95%
To view Transcend Therapeutics’s complete cap table history, request access »

Transcend Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of a neuroscience-focused clinical-stage company intended to develop psychoactive medicines for neuropsychiatri
Drug Discovery
New York, NY
14 As of 2024

Lexington, MA
 

Boston, MA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Transcend Therapeutics Competitors (49)

One of Transcend Therapeutics’s 49 competitors is Voyager Therapeutics, a Formerly VC-backed company based in Lexington, MA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Voyager Therapeutics Formerly VC-backed Lexington, MA
Cerevance Venture Capital-Backed Boston, MA
Cognition Therapeutics Formerly VC-backed New York, NY
Neumora Formerly VC-backed Watertown, MA
Alzheon Venture Capital-Backed Framingham, MA
You’re viewing 5 of 49 competitors. Get the full list »

Transcend Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Transcend Therapeutics Former Investors (12)

Investor Name Investor Type Holding Investor Since Participating Rounds
AlleyCorp Venture Capital Minority
Alpha Wave Global Growth/Expansion Minority
Alumni Ventures Venture Capital Minority
Brown Angel Group Angel Group Minority
Concentric (London) Venture Capital Minority
You’re viewing 5 of 12 investors. Get the full list »

Ready to get started?

Request a free trial

Transcend Therapeutics FAQs

  • When was Transcend Therapeutics founded?

    Transcend Therapeutics was founded in 2021.

  • Where is Transcend Therapeutics headquartered?

    Transcend Therapeutics is headquartered in New York, NY.

  • What is the size of Transcend Therapeutics?

    Transcend Therapeutics has 14 total employees.

  • What industry is Transcend Therapeutics in?

    Transcend Therapeutics’s primary industry is Drug Discovery.

  • Is Transcend Therapeutics a private or public company?

    Transcend Therapeutics is a Private company.

  • What is the current valuation of Transcend Therapeutics?

    The current valuation of Transcend Therapeutics is .

  • What is Transcend Therapeutics’s current revenue?

    The current revenue for Transcend Therapeutics is .

  • How much funding has Transcend Therapeutics raised over time?

    Transcend Therapeutics has raised $41.5M.

  • Who are Transcend Therapeutics’s investors?

    AlleyCorp, Alpha Wave Global, Alumni Ventures, Brown Angel Group, and Concentric (London) are 5 of 12 investors who have invested in Transcend Therapeutics.

  • Who are Transcend Therapeutics’s competitors?

    Voyager Therapeutics, Cerevance, Cognition Therapeutics, Neumora, and Alzheon are some of the 49 competitors of Transcend Therapeutics.

  • When was Transcend Therapeutics acquired?

    Transcend Therapeutics was acquired on 12-Jun-2026.

  • Who acquired Transcend Therapeutics?

    Transcend Therapeutics was acquired by Otsuka Pharmaceutical.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process